3.
Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects Anna Wuolikainen,P?r Jonsson,Maria Ahnlund,Henrik Antti,Stefan L. Marklund,Thomas Moritz,Lars Forsgren,Peter M. Andersen,Miles Trupp Mol. BioSyst. 2016 12 1287
4.
Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach Aihua Zhang,Hui Sun,Ying Han,Ye Yuan,Ping Wang,Gaochen Song,Xiaoxia Yuan,Miao Zhang,Ning Xie,Xijun Wang Analyst 2012 137 4200
5.
Profiling of phenolic and other compounds from Egyptian cultivars of chickpea (Cicer arietinum L.) and antioxidant activity: a comparative study Reham Hassan Mekky,María del Mar Contreras,Mohamed Roshdi El-Gindi,Azza R. Abdel-Monem,Essam Abdel-Sattar,Antonio Segura-Carretero RSC Adv. 2015 5 17751
7.
RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer Yanhua Chen,Ruiping Zhang,Yongmei Song,Jiuming He,Jianghao Sun,Jinfa Bai,Zhuoling An,Lijia Dong,Qimin Zhan,Zeper Abliz Analyst 2009 134 2003
8.
Purines, pyrimidines, and imidazoles. Part 50. Inhibition of adenylosuccinate AMP-lyase no. 4.3.2.2. by derivatives of N-(5-amino-1-β-D-ribofuranosylimidazole-4-carbonyl)-L-aspartic acid 5′-phosphate (SAICAR) and virazole 5′-phosphate Gordon Shaw,Peter S. Thomas,Carole A. H. Patey,Susan E. Thomas J. Chem. Soc. Perkin Trans. 1 1979 1415